Why You Should Attend!



The pharmaceutical and biotech industries are in the midst of significant change- change in the innovation process, new markets of interest and changes in the financing model. These changes have prompted continued discussion on the future of investment in the sector as well as discussion as to where new opportunities may lie.

On June 14th, when Argyle Executive Forum will host its Leadership in Pharmaceuticals and Biotechnology meeting, taking place in Manhattan, life science leaders will meet to discuss the full implications of these changes.

This event will feature insights from top executives, including:

Speaker
Robert Cobuzzi SVP Corporate Development
Endo Pharmaceuticals
View Bio »
Speaker
Daniel Cohen Vice President Corporate Development
Catalent Pharma Solutions
View Bio »
Speaker
Chris Garabedian President & CEO
AVI BioPharma
View Bio »
Speaker
Adam Golden Partner
Kaye Scholer
View Bio »
Speaker
Milton Grannatt VP & Head, Negotiations, Respiratory & New Growth Opportunities Global Bus. Dev.
Novartis
View Bio »
Speaker
Jonathan Isler Partner, Transaction Services
PwC
View Bio »
Speaker
Ruhi Khan VP, Business Development
Acorda Therapeutics Inc.
View Bio »
Speaker
Anup Kharode Director- Pharmaceutical & Life Sciences R&D Advisory Services
PwC
View Bio »
Speaker
Sharon Kochan Executive Vice President and GM
Perrigo Co.
View Bio »
Speaker
Bob Little VP Marketing
Innography
View Bio »
Speaker
Ellen Lubman Former Group Director, Strategic Transactions Group
Bristol-Myers Squibb
View Bio »
Speaker
Ken Maynard Global Head, External Innovation, Aging, Therapeutic Strategic Unit
Sanofi-Aventis
View Bio »
Speaker
Garry Neil Corporate Vice President
Johnson & Johnson
View Bio »
Speaker
Adelene Perkins President and Chief Executive Officer
Infinity Pharmaceuticals Inc.
View Bio »
Speaker
Seth Rodner Executive Vice President, Chief Legal Officer & Corporate Secretary
Medicis Pharmaceutical Corporation
View Bio »
Speaker
Pol Vandenbroucke Vice President, Development, Emerging Markets
Pfizer
View Bio »
Speaker
Michael Wise Partner
A.T. Kearney
View Bio »
Speaker
Brett Zbar Partner
Aisling Capital
View Bio »
  • 8:00am – 9:00am Breakfast
  • 9:00am – 9:05am Argyle Executive Forum Opening Remarks
  • 9:05am – 9:35am "A Walk in the 'Park' This Ain't (or Clean Hands Can Still Be Cuffed): What Every Pharma Executive Needs to Know About RCO Enforcement"
    read more »

    Seth RodnerExecutive Vice President, Chief Legal Officer & Corporate SecretaryMedicis Pharmaceutical Corporation

  • 9:40am – 10:00am "Winning the Battle for Consumer Healthcare"
    read more »

    Global demographic changes are creating a new market for consumer-focused products with significant health benefits. This new "consumer healthcare" segment is emerging midway between mass retail-based consumer goods and pharmacy-based pharmaceuticals—and it will be a new battleground between the giants in these two industries. Which industry will win? It's not yet clear. Consumer goods companies boast strengths in marketing and distribution but are weak on science, an area in which pharmaceutical companies excel. The unique challenges of this new segment will likely require a mixed model, with capabilities from each industry.

    Michael WisePartner, Vice PresidentA.T. Kearney

  • 10:05am – 10:55am Panel Discussion
    read more »

    “The Future of R&D”

    Session topics include, but not limited to:

    • New business and financing models for innovation
    • Using partnerships to access early stage research and opportunities
    • Sharing the risks and costs of new drug development
    • New opportunities in the emerging markets
    • Partnering with academia
    • Open innovation
    Moderator:Jonathan IslerPartner, Transaction ServicesPwCPanelists:Anup KharodeDirector- Pharmaceutical & Life Sciences R&D Advisory ServicesPwCKen MaynardGlobal Head, External Innovation, Aging, Therapeutic Strategic UnitSanofi-AventisGarry NeilCorporate Vice PresidentJohnson & JohnsonPol VandenbrouckeVice President, Development, Emerging MarketsPfizer

  • 10:55am – 11:30am Coffee
  • 11:30am – 12:20pm Panel Discussion
    read more »

    “Deal Making in Pharmaceuticals & Biotechnology”

    Session topics include, but not limited to:

    • Current market information and deal drivers
    • Recent trends in deal structuring
    • The incorporation of risk sharing intro transactions
    • Determining which deal structure will lead to the greatest return on your investment
    • Key components to consider in valuing a life science asset
    Moderator:Adam GoldenPartnerKaye ScholerPanelists:Daniel CohenVice President Corporate DevelopmentCatalent Pharma SolutionsEllen LubmanFormer Group Director, Strategic Transactions GroupBristol-Myers SquibbBrett ZbarPartnerAisling Capital*This session is off the record

  • 12:25pm – 12:55pm "The Rise of the Rare Disease Business Model"
    read more »

    Chris GarabedianPresident & CEOAVI BioPharma

  • 12:55pm – 1:55pm Lunch
  • 1:55pm – 2:45pm Panel Discussion
    read more »

    “Developing an Effective Business Development Strategy”

    Session topics include, but not limited to:

    • Latest trends in business development
    • Portfolio management as a business development strategy
    • Evaluating and negotiating partnerships
    • Licensing trends- potential areas for growth
    • Managing your pipeline- business development’s role
    Moderator:Bob LittleVP MarketingInnographyPanelists:Milton GrannattVP & Head, Negotiations, Respiratory & New Growth Opportunities Global Bus. Dev.NovartisRuhi KhanVP, Business DevelopmentAcorda Therapeutics Inc.Adelene PerkinsPresident and Chief Executive OfficerInfinity Pharmaceuticals Inc.*This session is off the record

  • 2:50pm – 3:20pm “The U.S. Generic Market - Trends, Opportunities & Issues”
    read more »

    Sharon KochanExecutive Vice PresidentPerrigo Co.

  • 3:25pm – 3:55pm "Navigating the Complexity of 'Convergent' Deals for Healthcare Products and Services"
    read more »

    Deal making is about solving problems and creating value, for target customers and shareholders. The US and global healthcare markets are evolving rapidly with an enhanced focus placed on the value of care. The value creation equation has consequently changed in a manner that increases Commercialization risk, and thus competition for value-creating assets is reported to be increasing across all segments of healthcare. This presentation will focus on the Endo experience of addressing these issues through deal making that considers the convergence of drugs, devices and services in healthcare delivery.

    Robert CobuzziSVP Corporate DevelopmentEndo Pharmaceuticals

  • 3:55pm – 4:00pm Argyle Executive Forum Closing Remarks
  • 4:00pm – 5:00pm Cocktail Reception
    read more »

    *Please note, the agenda is subject to change.

Still have questions? We have answers.

I want to attend, but what if I'm unsure of my schedule and need to cancel my participation?

Just let us know. We understand that schedules change! However, we always have a waiting list for this event, and if you don't cancel, we will assume you are still attending and your spot will go unused. If you must, cancel at least 48 hours prior to the event to make room for others!

What if I can't be OOO for a whole day, or need to come late?

We have wifi and private rooms available for attendees to take calls and spend some quiet time on emails, as well as access to printing. Have a morning meeting you can't miss? No problem. This event was designed for busy executives - we get it.

I'd like to bring some colleagues. Do I need to register them online?

Events are more fun with friends, and we'd be happy to host your team. You can have them register online, or send us their names, titles and email addresses and we will take care of it for you!

I don't see the event venue listed. Where will the meeting be held?

To maintain exclusivity, we don't release the venue address until the registration process has been completed. All logistical details will be shared once you have requested a pass and been approved.

"The 2012 Leadership in Pharmaceuticals & Biotechnology in New York"
is proudly sponsored by:

Traveling for the event? Stay at one of our recommended hotels nearby:

Please note the below is a preferred hotel of Argyle Executive Forum. Please specify that you are requesting the Argyle Executive Forum rate when booking sleeping rooms in order to receive a discounted rate of $279.00 per night, taxes not included. Reservations may also be made by emailing reservations@fitzpatrickhotels.com.

Venue

The Fitzpatrick Grand Central

141 E. 44th Street
New York, NY 10017
Telephone: (800) 367-7701
Website

Continuing Education Credits:

Please note that Continuing Education credits are not offered for this meeting